Ethyl 2-(triphenylphosphoranylidene)propanoate, 94.0%, 25g

4-(Trifluoromethylthio)phenol>98.0%(GC)5g

2,4,5-Trimethoxybenzoic acid, 95.0%, 500g

Methyl 3-(4-hydroxy-3,5-dimethoxyphenyl)acrylate, 95.0%, 5g

2-Hydroxy-1-(4-(2-hydroxyethoxy)phenyl)-2-methylpropan-1-one, 97.00%, 100g

Ethyl 2-(4-amino-3-cyanophenyl)acetate, 95%, 100mg

AZTREONAM, 95%, 250mg

7-chloro-2-(chloromethyl)quinazolin-4(3H)-one, 95.0%, 250mg

4-Bromo-1,1':3',1''-terphenyl, 95.0%, 5g

4-Bromo-2-chloro-5-(difluoromethyl)pyridine, 98%, 50mg

(3R,4R)-tert-Butyl 3-bromo-4-hydroxypyrrolidine-1-carboxylate, 100mg

GC capillary column ROTI®Cap-1701 MS, 60 m, 0.25 mm, 0.50 µm, 1 Piece(s)

2-Bromo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiazole, 97%, 1g